老板办公室乳摸GIF动态图,色婷婷亚洲一区二区三区,国产全是老熟女太爽了,欧美极度残忍变态另类电影
<abbr id="s4888"><sup id="s4888"></sup></abbr>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.01.11
關(guān)于收到中國證監(jiān)會不予核準公司發(fā)行股份購買資產(chǎn)決定的公告
2018.01.06
第四屆董事會第九次會議決議公告
2018.01.06
關(guān)于公司和全資孫公司共同對外投資的公告
2017.12.28
關(guān)于公司發(fā)行股份購買資產(chǎn)暨關(guān)聯(lián)交易事項未獲得中國證監(jiān)會上市公司并購重組審核委員會...
2017.12.21
關(guān)于《中國證監(jiān)會行政許可項目審查一次反饋意見通知書》之反饋意見回復(fù)的修訂公告
2017.12.21
關(guān)于《中國證監(jiān)會行政許可項目審查一次反饋意見通知書（172046號）》之反饋意見回復(fù)（修訂稿...
2017.12.21
關(guān)于深圳市多普樂實業(yè)發(fā)展有限公司報告期業(yè)績真實性之專項核查報告
2017.12.21
沃克森（北京）國際資產(chǎn)評估有限公司關(guān)于中國證監(jiān)會對關(guān)于公司發(fā)行股份購買資產(chǎn)申請的反...
2017.12.21
發(fā)行股份購買資產(chǎn)暨關(guān)聯(lián)交易報告書摘要（修訂稿）
2017.12.21
發(fā)行股份購買資產(chǎn)暨關(guān)聯(lián)交易報告書（修訂稿）
第一頁
上一頁
64
65
66
67
68
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
